Search
Search Results
##search.searchResults.foundPlural##
-
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3396PDF: 1778HTML: 1172 -
-
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS
2351PDF: 828HTML: 1307 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2540HTML: 9432DOCX: 1062Tables Dengue: 255 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1920PDF: 792HTML: 560 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1338PDF: 565HTML: 23228 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3923PDF: 1567HTML: 352 -
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2181PDF: 885HTML: 263 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3849PDF: 1169HTML: 2483Figure 1: 241 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2481PDF: 1060HTML: 1670Fig 1: 232Tab I: 253Cover Letter: 255 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2913PDF: 976HTML: 307 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4741PDF: 2025HTML: 18187 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
265PDF: 382Suppl. Files: 74HTML: 169 -
-
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2164PDF: 1107HTML: 15741COVER LETTER: 233 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2230PDF: 901HTML: 370 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4642PDF: 3826HTML: 378 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1715PDF: 778HTML: 1488 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2444PDF: 1018HTML: 11170 -
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
386PDF: 397HTML: 203 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3947PDF: 1750HTML: 11906Figures Haase: 257 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2255PDF: 1068HTML: 4108Cover Letter: 257Figure 1: 271Figure 2: 266Table 1: 247 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2805PDF: 1083HTML: 2396 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1988PDF: 1228HTML: 343 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3501PDF: 1575HTML: 4086







